Anabolic-androgenic steroids and cardiovascular risk
JD Liu, YQ Wu - Chinese medical journal, 2019 - mednexus.org
Objective: Anabolic-androgenic steroids (AAS) represents a group of synthetic testosterone
derivatives that play an important role in clinical treatment. These drugs are widely abused …
derivatives that play an important role in clinical treatment. These drugs are widely abused …
Androgen therapy in women
S Vegunta, JM Kling, E Kapoor - Journal of women's health, 2020 - liebertpub.com
Androgens are believed to have an important biologic role in women, particularly in
regulation of libido and sexual arousal, although much about their function on other systems …
regulation of libido and sexual arousal, although much about their function on other systems …
Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development
Breast and prostate cancer are two of the most common malignancies worldwide. Both
cancers can develop into hormone–dependent or–independent subtypes and are …
cancers can develop into hormone–dependent or–independent subtypes and are …
Dietary phenolics against breast cancer. A critical evidence-based review and future perspectives
MÁ Ávila-Gálvez, JA Giménez-Bastida… - International journal of …, 2020 - mdpi.com
Breast cancer (BC) is the most common malignancy and the leading cause of cancer-related
death in adult women worldwide. Over 85% of BC cases are non-hereditary, caused by …
death in adult women worldwide. Over 85% of BC cases are non-hereditary, caused by …
[HTML][HTML] Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening
AC Fledderus, HA Gout, AC Ogilvie, DKG van Loenen - The Breast, 2020 - Elsevier
Abstract Background Female-to-male (FtM) transsexuals may use testosterone therapy for
masculinization, which potentially influences the risk of breast cancer development. Guided …
masculinization, which potentially influences the risk of breast cancer development. Guided …
The effects of metformin and weight loss on biomarkers associated with breast cancer outcomes
RE Patterson, CR Marinac, DD Sears… - JNCI: Journal of the …, 2018 - academic.oup.com
Background This study investigated the effects of metformin and weight loss on biomarkers
associated with breast cancer prognosis. Methods Overweight/obese postmenopausal …
associated with breast cancer prognosis. Methods Overweight/obese postmenopausal …
Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: A systematic review with network meta …
K Bae, G Lamoury, S Carroll, M Morgia, S Lim… - Critical Reviews in …, 2023 - Elsevier
Aromatase inhibitor-induced arthralgia (AIA) contributes to poor adherence of aromatase
inhibitor therapies in patients with breast cancer. A systematic review using network meta …
inhibitor therapies in patients with breast cancer. A systematic review using network meta …
Based on BATMAN-TCM to explore the molecular mechanism of Xihuang Pill regulating immune function to treat breast precancerous lesions
D Li, H Fan, J Dong, C Sun, Y Su, J Liu… - Breast Cancer: Targets …, 2021 - Taylor & Francis
Objective The specific mechanism of Xihuang Pill in the treatment of breast precancerous
lesions and breast cancer has not yet been elucidated. Methods In our study, BATMAN-TCM …
lesions and breast cancer has not yet been elucidated. Methods In our study, BATMAN-TCM …
Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study
RL Glaser, AE York, C Dimitrakakis - BMC cancer, 2019 - Springer
Background Testosterone implants have been used for over eighty years to treat symptoms
of hormone deficiency in pre and postmenopausal women. Evidence supports that …
of hormone deficiency in pre and postmenopausal women. Evidence supports that …
The role of testosterone in menopausal hormone treatment. What is the evidence?
N Johansen, A Linden Hirschberg… - Acta Obstetricia et …, 2020 - Wiley Online Library
About 40% of postmenopausal women have decreased sexual desire, causing distress.
Estrogen therapy attenuates vaginal complaints but has no effect on sexual desire. Although …
Estrogen therapy attenuates vaginal complaints but has no effect on sexual desire. Although …